NovoCure announces that the U.S. FDA has approved its Optune Pax device for use with chemotherapy in treating adult patients with locally advanced pancreatic cancer.
https://finviz.com/quote.ashx?t=NVCR&p=d
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.